ARIAD Pharmaceuticals Competitors and Similar CompaniesClear all
ARIAD Pharmaceuticals's competitors and similar companies include GlycoMimetics.
 ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | |
Founding Date | Founding Date 1991 | Founding Date 2003 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Rockville, US HQ |
Employees | Employees 1381% increase | Employees 5025% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $10.8m (FY, 2025) |
Net income | Net income ($231.2m) (FY, 2015) | Net income ($153.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company